NEW YORK (360Dx) – Quanterix announced on Monday it and BioMérieux have signed a new licensing deal giving both firms greater flexibility to commercialize products within their respective fields.

As part of the new agreement, Quanterix will have broader licensing rights within the in vitro diagnostic field, and it and BioMérieux will have the ability to develop instruments for commercialization within the IVD space, Quanterix said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.